Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

BBOT · Insider trading · 13F holders · Congress trades

BridgeBio Oncology Therapeutics, Inc. (BBOT)

Who is buying and selling BBOT: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.

13F filers holding
15
Insider buys, 90 days
$0
Insider sales, 90 days
$0
Congress trades, 12 months
0

BBOT at a glance

  • No open-market insider purchases or sales of BBOT were filed in the last 90 days.
  • 15 13F filers hold BBOT among their 50 largest positions, worth $323.3M combined, including Oleg Nodelman and James Flynn. The biggest bets by portfolio weight are Omega Fund Management, LLC (13.5%), Cormorant Asset Management, LP (7.0%) and Aisling Capital Management LP (1.6%). In their latest 13Fs, 2 managers opened a new position and 0 added to one.
  • No member of Congress has disclosed a trade in BBOT.

BBOT insider trading

No open-market insider purchases or sales of BBOT were filed in the last 90 days.

Who owns BBOT? Hedge funds and superinvestors

15 13F filers hold BBOT among their 50 largest positions, worth $323.3M combined, including Oleg Nodelman and James Flynn. The biggest bets by portfolio weight are Omega Fund Management, LLC (13.5%), Cormorant Asset Management, LP (7.0%) and Aisling Capital Management LP (1.6%). In their latest 13Fs, 2 managers opened a new position and 0 added to one.

Superinvestors holding BBOT: Oleg Nodelman 1.1% · James Flynn 0.5%

13F filers holding BBOT
Manager% of portfolioValueSharesLast quarter13F
Cormorant Asset Management, LPHedge fund7.0%$136.2M17,878,594+0.0% sharesQ2 2026
James FlynnHedge fund0.5%$37.2M4,885,446+0.0% sharesQ2 2026
Omega Fund Management, LLCHedge fund13.5%$25.1M3,289,661+0.0% sharesQ2 2026
Oleg NodelmanHedge fund1.1%$21.5M2,823,126+0.0% sharesQ2 2026
Alphabet Inc.Corporation0.0%$21.5M2,823,126+0.0% sharesQ2 2026
Enavate Sciences Gp, LLCInvestment manager5.8%$20.0M2,626,946+0.0% sharesQ2 2026
Novo Holdings A/sInvestment manager1.0%$17.1M2,250,000+2.9% sharesQ2 2026
Laurion Capital Management LPHedge fund1.2%$15.3M2,002,701+4.2% sharesQ2 2026
Regents of the University of CaliforniaEndowment & foundation0.2%$10.3M2,509,446NewQ3 2026
Aisling Capital Management LPHedge fund1.6%$7.8M1,018,018+0.0% sharesQ2 2026
Opaleye Management Inc.Hedge fund0.5%$5.3M700,000—Q2 2026
Catalio Capital Management, LPHedge fund0.5%$2.4M318,407NewQ2 2026
Casdin Capital, LLCHedge fund0.1%$2.2M282,312+0.0% sharesQ2 2026
Sio Capital Management, LLCHedge fund0.2%$995K130,628—Q2 2026
Avidity Partners Management LPHedge fund0.1%$334K43,853+0.0% sharesQ2 2026

Each manager counts with its latest 13F (Q3 2026: 1, Q2 2026: 14). Screen BBOT in the grand portfolio →

BBOT stock trades by members of Congress

No member of Congress has disclosed a trade in BBOT.

BBOT questions and answers

Are insiders buying BBOT stock?

No open-market insider purchases or sales of BBOT were filed in the last 90 days.

Which hedge funds own BBOT?

15 13F filers hold BBOT among their 50 largest positions, worth $323.3M combined, including Oleg Nodelman and James Flynn. The biggest bets by portfolio weight are Omega Fund Management, LLC (13.5%), Cormorant Asset Management, LP (7.0%) and Aisling Capital Management LP (1.6%). In their latest 13Fs, 2 managers opened a new position and 0 added to one.

Has Congress traded BBOT?

No member of Congress has disclosed a trade in BBOT.

Who is the largest holder of BBOT?

Among 13F filers, Cormorant Asset Management, LP reports the largest BBOT position, $136.2M (17,878,594 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is Omega Fund Management, LLC's: 13.5% of its portfolio.

Cite or share this

Free to use with a link back. The data updates every filing day.

Citation
Link